Latest News and Press Releases
Want to stay updated on the latest news?
-
Longboard Pharmaceuticals Provides Corporate Update and Reports First Quarter 2021 Financial Results
Commenced multiple ascending dose (MAD) portion of the Phase 1 study for LP352, a potential treatment for severe epileptic indications; topline results expected in the second half of 2021 ...
-
Gaithersburg, MD, March 29, 2021 (GLOBE NEWSWIRE) -- Verus International, Inc. (“Verus” or the “Company”) (OTC Pink: VRUS) reported financial results for the fiscal 2021 first quarter ended January...